Nisa Investment Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Nisa Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$680K	Buy	20,073 +5,948	+42%	+$198K	﹤0.01%	896
2026 Q1	$425K	Buy	14,125 +941	+7%	+$30.3K	﹤0.01%	1008
2025 Q4	$411K	Buy	+13,184	New	+$325K	﹤0.01%	1059
2023 Q2	–	Sell	-15,890	Closed	-$141K	–	2869
2023 Q1	$141K	Buy	15,890 +774	+5%	+$7.65K	﹤0.01%	1389
2022 Q4	$138K	Sell	15,116 -10,712	-41%	-$93.5K	﹤0.01%	1455
2022 Q3	$208K	Sell	25,828 -96,023	-79%	-$849K	﹤0.01%	1264
2022 Q2	$916K	Buy	121,851 +35,968	+42%	+$313K	0.01%	850
2022 Q1	$806K	Sell	85,883 -8,252	-9%	-$68.9K	0.01%	941
2021 Q4	$794K	Buy	+94,135	New	+$850K	0.01%	895
2021 Q2	–	Sell	-23,340	Closed	-$269K	–	2384
2021 Q1	$269K	Buy	+23,340	New	+$268K	﹤0.01%	1383
2020 Q3	–	Sell	-74,443	Closed	-$918K	–	2266
2020 Q2	$918K	Buy	+74,443	New	+$842K	0.01%	814
2019 Q3	–	Sell	-126	Closed	-$1K	–	2045
2019 Q2	$1K	Sell	126 -247	-66%	-$2.98K	﹤0.01%	2008
2019 Q1	$6K	Sell	373 -19,020	-98%	-$335K	﹤0.01%	1878
2018 Q4	$299K	Sell	19,393 -3,900	-17%	-$80K	﹤0.01%	1137
2018 Q3	$504K	Buy	23,293 +22,920	+6,145%	+$532K	﹤0.01%	1091
2018 Q2	$11K	Sell	373 -101	-21%	-$2.06K	﹤0.01%	1712
2018 Q1	$13K	Hold	474	–	–	﹤0.01%	1579
2017 Q4	$13K	Hold	474	–	–	﹤0.01%	1680
2017 Q3	$14K	Buy	474 +3	+0.6%	+$68	﹤0.01%	1643
2017 Q2	$17K	Sell	471 -206	-30%	-$6.38K	﹤0.01%	1534
2017 Q1	$25K	Hold	677	–	–	﹤0.01%	1477
2016 Q4	$25K	Hold	677	–	–	﹤0.01%	1569
2016 Q3	$31K	Sell	677 -34	-5%	-$1.77K	﹤0.01%	1509
2016 Q2	$37K	Buy	711 +88	+14%	+$4.68K	﹤0.01%	1435
2016 Q1	$33K	Buy	+623	New	+$36.6K	﹤0.01%	1457

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Nisa Investment Advisors's TEVA Position: Q2 2026 in Review

Nisa Investment Advisors increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 42% in Q2 2026, buying an estimated $198K and bringing the position to 20,073 shares worth $680K. The position accounts for ﹤0.01% of the portfolio, ranked #896.

Nisa Investment Advisors first reported a position in TEVA in Q1 2016 and has held it in 25 quarters since. The position peaked at $918K in Q2 2020. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Nisa Investment Advisors held 20,073 shares of Teva Pharmaceutical Industries Limited worth $680K as of Q2 2026.
Nisa Investment Advisors bought 5,948 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $198K.
Teva Pharmaceutical Industries Limited made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #896 holding.
Nisa Investment Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q1 2016 and has held it in 25 quarters since.
Nisa Investment Advisors's Teva Pharmaceutical Industries Limited position peaked at $918K in Q2 2020.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.